AtriCure provides atrial fibrillation solutions to medical centers. The Company offers innovative solutions for ablation, such as Isolator Synergy and Isolator Synergy Access clamps, COBRA Fusion surgical ablation system and EPi-Sense guided coagulation system. It also provides SUBTLE cannula, multifunctional pens and linear ablation devices. In addition, the Company offers cryoICE cryoablation system, AtriClip system, Lumitip dissector and Estech cardiac surgery instruments.
Type
Public
HQ
Mason, US
Founded
2000
Size (employees)
500 (est)
AtriCure was founded in 2000 and is headquartered in Mason, US
Report incorrect company information

Key People/Management at AtriCure

Michael Carrel

Michael Carrel

President & CEO
Douglas Seith

Douglas Seith

Chief Operating Officer
Andrew Wade

Andrew Wade

VP & CFO
Sam Privitera

Sam Privitera

Chief Technical Officer
Karl Dahlquist

Karl Dahlquist

Vice President, Legal and Chief Compliance Officer
Tonya Austin

Tonya Austin

Vice President, Human Resources

AtriCure Office Locations

AtriCure has offices in Allen, Dallas, Allentown, Houston and in 28 other locations
Mason, US (HQ)
7555 Innovation Way
Minnetonka, US
250 130 Cheshire Ln
San Ramon, US
110 2420 Camino Ramon
West Chester, US
6217 Centre Park Drive
Amsterdam-Zuidoost, NL
260 De Entree
Show all (32)
Report incorrect company information

AtriCure Financials and Metrics

AtriCure Financials

AtriCure's revenue was reported to be $174.72 m in FY, 2017
USD

Revenue (FY, 2017)

174.7 m

Gross profit (FY, 2017)

126.2 m

Gross profit margin (FY, 2017), %

72.2%

Net income (FY, 2017)

(26.9 m)

EBIT (FY, 2017)

(25 m)

Market capitalization (20-Apr-2018)

687.2 m

Cash (31-Dec-2017)

21.8 m

EV

689.5 m
AtriCure's current market capitalization is $687.2 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

81.9 m107.5 m129.8 m155.1 m174.7 m

Revenue growth, %

31%21%20%

Cost of goods sold

22.3 m31.7 m36.9 m44 m48.6 m

Gross profit

59.6 m75.8 m92.9 m111.1 m126.2 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

20.1 m24.8 m26.5 m26.7 m29.9 m32.6 m31.4 m35.9 m39.7 m38.3 m41.3 m45.2 m42.2 m

Cost of goods sold

5.5 m7.2 m7.7 m7.8 m8.2 m9.5 m8.9 m10 m10.9 m10.9 m11.3 m12.7 m11.2 m

Gross profit

14.7 m17.7 m18.8 m18.9 m21.7 m23.1 m22.5 m25.9 m28.8 m27.5 m30 m32.6 m30.9 m

Gross profit Margin, %

73%71%71%71%73%71%72%72%73%72%73%72%73%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

14.9 m28.4 m23.8 m24.2 m21.8 m

Accounts Receivable

Inventories

10.2 m14.3 m17.7 m17.7 m22.5 m

Current Assets

52.5 m93.5 m74.8 m85.7 m82.3 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

25.8 m68.6 m42 m35.5 m23.6 m30 m28.7 m20.8 m19.9 m16.1 m19.2 m21 m19.4 m

Inventories

7.1 m11.1 m12.7 m14.6 m15.1 m16.1 m16.6 m19 m19.3 m19 m18.8 m19.9 m22.6 m

Current Assets

48.6 m107.2 m92.8 m90.7 m93.4 m90.7 m84.1 m65.4 m86.5 m84.4 m79.1 m81.1 m82.1 m

PP&E

4.1 m5.8 m6.5 m9.8 m13.9 m19.4 m27.5 m31.2 m30.9 m30.7 m29.9 m30 m29.3 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(11.5 m)(16.2 m)(27.2 m)(33.3 m)(26.9 m)

Depreciation and Amortization

2 m4.8 m6.3 m9.3 m7.8 m

Inventories

(2.3 m)(4.3 m)(3 m)(79 k)(4.5 m)

Accounts Payable

1.4 m(944 k)4 m(1.1 m)1.3 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(2.7 m)(7.7 m)(2.7 m)(466 k)(5.3 m)(4.9 m)(6.1 m)(9.7 m)(8.2 m)(6.8 m)(10.2 m)

Inventories

12.7 m14.6 m15.1 m16.1 m16.6 m19 m19.3 m19 m18.8 m

Accounts Payable

7.5 m7.8 m9.7 m9.3 m11.2 m12.8 m11.9 m11 m11.3 m
USDY, 2017

EV/EBIT

-27.6 x

EV/CFO

-77.1 x

Revenue/Employee

349.4 k

Financial Leverage

1.7 x
Show all financial metrics
Report incorrect company information

AtriCure News and Updates

Left Atrial Appendage (LAA) Closure Devices Market to Make Great Impact in Near Future by 2025

The North America is dominating and contributed the leading shares to the global left atrial appendage (LAA) closure devices market in terms of revenue and expected to register a significant growth during forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information